The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Cell Invent

Cell Invent logo

 

Alzheimer’s disease causes great suffering for patients and relatives and is among the costliest diseases for society. There is still no cure.

The researchers behind Cell Invent has a long and excellent track record in longitudinal dementia research and represent a unique combined expertise in preclinical and clinical Alzheimer’s disease.

Cell Invent offers a new way to find Alzheimer’s cures by developing new human disease models using reprogrammed Alzheimer patient cells.

 

Cell Invent webpage

 

 

Cell Invent

Develops new human disease models based on reprogrammed Alzheimer patient cells.

Founded by Håkan Toresson, Lennart Minthon, Oskar Hansson and Camilla Orbjörn.

 

Portfolio company since 2019.

 

Portföljansvarig LU Holding:

christine [dot] widstrand [at] innovation [dot] lu [dot] se (Christine Widstrand), telefon +46 70 928 63 78

8 Sep 2020